drugset / Trial / NCT03584074

Clinical Trial of Pregabalin and COX2 in Spinal Stenosis

NCT03584074

Phase 4 Unknown 60 enrolled Seoul National University Bundang Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Aim of this prospective, single-blind, randomized study was to compare the efficacy of the combination of celecoxib and pregabalin and celecoxib only monotherapy for treatment of chronic low-back pain.

Timeline

Start
2018-07-01
Primary completion
2019-05-30
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg Oral
Subject Pregabalin Small molecule 75 mg Oral